Abstract: This invention provides a prophylactic and therapeutic agent for dry eye, having new ingredients to reduce the deterioration of the lacrimal secretory ability and to inhibit the generation of radical oxygen in lacrimal gland tissue. The prophylactic and therapeutic agent for dry eye of this invention contains the maqui berry extract as the active substance of this invention, i.e. containing delphinidin glycoside extracted from the maqui berry and at least one or more of the active substances delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, preferably delphinidin-3,5-diglucoside.

Abstract: An embodiment provides a working medium to be used in a circular osmotic pressure electric power generation system. The working medium comprises water and an inducing-liquid. The working medium, under conditions of a temperature of 5° C. to 35° C. and a pressure of 1 atmosphere, is in (1) a state of a liquid-liquid mutually dissolved two-component mixed solution when a concentration of the water or the inducing-liquid in the total amount of the water and the inducing-liquid is 10% by weight or lower, and (2) a state of being separated into the water phase and the inducing-liquid phase when the concentration of the water or the inducing-liquid in the total amount of the water and the inducing-liquid is higher than 10% by weight.

Abstract: A rare earth adsorbent of an embodiment has a chelidonic acid monoamide group as a ligand, and contains a functional group represented by the following general formula (1): wherein: X is selected from hydrogen or an alkali metal; R1 is a bonding group with a simple polymer; and R2 is a functional group selected from hydrogen, an alkyl group, an alkenyl group, an alkynyl group, and an aryl group, and may be substituted by nitrogen or oxygen or contain a functional group containing the atoms in a side chain.

Abstract: According to one embodiment, a water treatment system includes a first chamber which accommodates water to be treated, a second chamber which accommodates a working medium which induces an osmotic pressure and an osmosis membrane which separates the first chamber and the second chamber from each other. The working medium is an aqueous solution which contains an acid having a hydroxy group in a side chain, or a metal salt thereof.

Abstract: According to one embodiment, a water treatment method is a method configured to use a working medium that includes a draw solution and a water-containing solution to be treated. The draw solution is a hyperosmotic solution which generates an osmotic pressure difference with water. The method includes generating a flux of a mixture of water and a draw solution by an osmotic pressure difference generated between a solution to be treated and the draw solution in an osmotic pressure generator compartmentalized by an osmosis membrane, transferring the flux of the mixture to a vaporization-separation unit, separating the mixture into the water and the draw solution by a pressure difference, and recycling the draw solution separated by the vaporization-separation unit.

Abstract: A halogen oxyacid adsorbent of the present embodiment contains: a support material having a surface made of at least alumina; tetravalent cerium supported on the surface; and negative ions supported on the surface.

Abstract: An adsorbent containing graphene oxide having a shoulder peak at a wavelength of about 300 nm, wherein an absorbance at 600 nm is not less than 15% and not more than 60% of an absorbance at 300 nm, and an adsorption apparatus having an adsorption tank containing the adsorbent can be obtained.

Abstract: A rare earth adsorbent of an embodiment has a chelidonic acid monoamide group as a ligand, and contains a functional group represented by the following general formula (1): wherein: X is selected from hydrogen or an alkali metal; R1 is a bonding group with a simple polymer; and R2 is a functional group selected from hydrogen, an alkyl group, an alkenyl group, an alkynyl group, and an aryl group, and may be substituted by nitrogen or oxygen or contain a functional group containing the atoms in a side chain.

Abstract: A chelating agent of the embodiment is an amide compound in which a hydrogen atom of an —NH— site or an —NH2— site in an amine compound is substituted with a functional group derived from diglycolic acid. The amine compound is selected from the group consisting of a compound represented by a following general formula (1) and a polyethyleneimine having a molecular weight of 200 to 100,000. In the general formula (1), x, y and z respectively represent a number of repetitions for —CH2—CH2—NH—, x represents an integer of 1 to 10, y represents an integer of 0 to 5, and z represents an integer of 0 to 5.

Abstract: An iodine adsorbent of an embodiment has a support, a first organic group bonded to the support and has a functional group containing nitrogen at least at a terminal, and silver bonded to the nitrogen-containing functional group.

Abstract: This invention provides a prophylactic and therapeutic agent for dry eye, having new ingredients to reduce the deterioration of the lacrimal secretory ability and to inhibit the generation of radical oxygen in lacrimal gland tissue. The prophylactic and therapeutic agent for dry eye of this invention contains the maqui berry extract as the active substance of this invention, i.e. containing delphinidin glycoside extracted from the maqui berry and at least one or more of the active substances delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, preferably delphinidin-3,5-diglucoside.

Abstract: An iodine adsorbent includes a carrier that is a compound containing silicon, an organic group bonded to the carrier, and silver. The organic group has, at the terminal, a functional group represented by S? or SR. The silver is bonded to sulfur in S? or SR. The R is a hydrogen atom or a substituent containing a hydrocarbon. Where the element ratio of sulfur in the adsorbent to silicon in the adsorbent is MS/MSi, MS/(MSi·A), a value obtained by dividing the element ratio by a specific surface area A (m2/g) of the carrier, is 2.4×10?4 g/m2?MS/(MSi·A)?2.7×10?4 g/m2.

Abstract: According to one embodiment, an osmosis membrane unit has an osmotic pressure inductor and an osmosis membrane. The osmotic pressure inductor is one in which a salt-structure compound has been made to react with a reticulate member composed of metal. The osmosis membrane is disposed to contact at least one surface of the osmotic pressure inductor.

Abstract: An embodiment provides a working medium to be used in a circular osmotic pressure electric power generation system. The working medium comprises water and an inducing-liquid. The working medium, under conditions of a temperature of 5° C. to 35° C. and a pressure of 1 atmosphere, is in (1) a state of a liquid-liquid mutually dissolved two-component mixed solution when a concentration of the water or the inducing-liquid in the total amount of the water and the inducing-liquid is 10% by weight or lower, and (2) a state of being separated into the water phase and the inducing-liquid phase when the concentration of the water or the inducing-liquid in the total amount of the water and the inducing-liquid is higher than 10% by weight.

Abstract: An iodine adsorbent of an embodiment includes a support, an organic group bonded to the support, silver, and chloride ions, bromide ions, or both of chloride ions and bromide ions. The organic group has, at the terminal, a functional group represented by S? or SR. The silver is bonded to S? or sulfur in SR. The R is a hydrogen atom or a substituent containing a hydrocarbon.

Abstract: A treatment system of the embodiment includes an osmotic pressure treatment unit having: a first tank which holds a treatment target solution, a second tank which holds a draw solution containing an osmotic pressure inducer and a solvent, and a semipermeable membrane which is interposed between the first tank and the second tank. The osmotic pressure inducer is prepared by chemically modifying a support with a polymer having an upper critical solution temperature or a lower critical solution temperature.

Abstract: There is provided an efficient treatment method for boron-containing water capable of reducing an amount of use of medical agent and an amount of generation of sludge. A treatment method for boron-containing water of an embodiment includes a first process of concentrating boron-containing water to obtain boron-concentrated liquid. Further, the method includes a second process of making the boron-concentrated liquid to be brought into contact with a layered inorganic hydroxide, and making the layered inorganic hydroxide adsorb boron in the boron-concentrated liquid to remove boron.

Abstract: According to one embodiment, a circulatory osmotic pressure electricity generation system configured to generate electricity by using a working medium, which includes an osmotic pressure generator, a turbine, a tank, a separating tower, a heat source and the working medium. The working medium has a critical temperature which separates a first temperature zone and a second temperature zone from each other and has a phase transition to a first phase or a second phase which occurs at the critical temperature. The osmotic pressure generator is placed under a temperature of the working medium within the first temperature zone, and comprises (i) a container, (ii) an osmosis membrane, (iii) a first inlet, (iv) a second inlet, and (v) an outlet.

Abstract: The present embodiment relates to a method for recovering a boron adsorbent, including: preparing water having an electric resistivity of 0.01 M?·cm or more and kept at a temperature within a temperature range; and contacting the water with the boron adsorbent to release boron adsorbed at the boron adsorbent.

Abstract: There is provided an efficient treatment method for boron-containing water capable of reducing an amount of use of medical agent and an amount of generation of sludge. A treatment method for boron-containing water of an embodiment includes a first process of concentrating boron-containing water to obtain boron-concentrated liquid. Further, the method includes a second process of making the boron-concentrated liquid to be brought into contact with a layered inorganic hydroxide, and making the layered inorganic hydroxide adsorb boron in the boron-concentrated liquid to remove boron.